Public Health Emergency - Leading a Nation Prepared
FDA issued an emergency use authorization (EUA) for Paxlovid for the treatment of mild-to-moderate coronavirus disease in adults & pediatric patients (12 yrs of age & older weighing at least 40 kg or about 88 lbs) with positive results of direct SARS-CoV-2 testing, & who are at high risk for progression to severe COVID-19, including hospitalization or death.
Today, the U.S. Food & Drug Administration issued an emergency use authorization for AstraZeneca’s Evusheld for the pre-exposure prevention of COVID-19 in certain adults & pediatric individuals (12 yrs of age & older weighing at least 40 kg [about 88 lbs]).
To address gaps in health care delivery during disasters, ASPR selects a fourth demonstration site for the Regional Disaster Health Response System, the Southern Regional Disaster Response System based at Emory University. The RDHRS sites form alliances & build specialized capabilities to improve health care readiness across the entire health care delivery system.
HHS activated its Emergency Prescription Assistance Program for Louisiana to give residents access to critical prescription medications and pay for prescription medications for people without health insurance affected by Hurricane Ida.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language | Vulnerability Disclosure Policy
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages